New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

National Healthcare Properties, Inc.

NHP

Real Estate Reit Healthcare Facilities

National Healthcare Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $342.3 million, down 3.25% from fiscal 2024.

Revenue
+19.8%
EPS
n/m
Free cash flow
n/m
Total debt
+79.0%

Quarter to September 2026, against a year earlier

14.82 0.31 +2.14%

After hours trading: 14.82, unchanged, last trade Fri 4:01pm Eastern.

Market cap
$985.7M
P/E
n/m
Fwd P/E FY26e
16.2×
Dividend yield
1.01%
F-score
5/9
ROIC
1.83%
Net debt / EBITDA
6.4×
Payout ratio
—

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 1.83% in Q3 FY26, the highest of these four quarters.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE−11.0%−11.5%−6.7%−3.1%
ROIC0.2%0.0%0.6%1.8%

Debt

Net debt is 8.25× a year’s EBITDA. Debt is 0.65× equity, against 1.12× in Q1 FY26.

Debt / equityNet debt / EBITDA
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Debt / equity1.1×1.1×0.5×0.7×
Net debt / EBITDA44.6×20.6×8.0×8.2×

Cash cycle, in days

Customers pay in 28 days and suppliers are paid in 192. Suppliers fund 164 days of working capital.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Cash cycle−41−40−52−164
Days to pay suppliers747382192
Days to be paid33333128

Per share, from Q4 FY25

Since Q4 FY25, per share: revenue has fallen 58.9%; book value has fallen 40.6%.

Free cash flowRevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Free cash flow1.0×0.3×−0.4×−0.7×
Revenue1.0×1.0×0.5×0.4×
Book value1.0×1.0×0.8×0.6×
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
3.22 2.62 0.99 0.99
P/FCF ratio
0.00 0.00 13.56 13.56
P/Operating CF
74.05 41.76 37.73 37.73
P/B ratio
1.27 0.85 0.57 0.57
Price to Tangible BV
1.27 0.85 0.57 0.57
EV/Sales
4.49 3.14 2.63 2.63
EV/EBITDA
13.79 12.99 11.98 11.98
EV/Operating CF
28.82 21.29 24.23 24.23
EV/FCF
(12.29) (17.19) 35.95 35.95
Quick Ratio
0.25 0.79 0.23 0.23
Current Ratio
0.25 0.79 0.23 0.23
Net Debt/EBITDA
8.25 7.98 20.58 44.56
Debt/Assets
31.42% 24.31% 39.33% 39.09%
Debt/Equity
0.65 0.45 1.12 1.11
Asset Turnover
0.20 0.18 0.19 0.19
Operating CF/Net income
0.89 (2.65) (1.19) (0.38)
Capex/Depreciation
(3.29) (6.00) (0.31) (0.10)
Interest Coverage
2.62 0.40 0.69 (0.41)
Selling, General and Administrative Expense of Revenue
7.57% 7.54% 6.34% 10.12%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
2.07% 1.85% 0.71% 2.21%
Graham Net Nets
(0.71) (0.65) (2.83) (2.83)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(6.49%) (12.83%) (21.67%) (21.67%)
Free Cash Flow Yield
(11.33%) (6.96%) 7.37% 7.37%
Revenue per Share
1.42 1.42 3.05 2.98
Operating CF per Share
0.22 0.35 0.32 0.35
Capex per Share
(1.07) (1.68) (0.19) (0.07)
Free Cash Flow per Share
(0.85) (1.33) 0.13 0.28
Cash per Share
1.98 4.91 3.76 3.83
Shareholders Equity per Share
12.68 17.16 21.05 21.36
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
12.68 17.16 21.05 21.36
Free Cash Flow
(62.06) (81.77) 3.75 8.01
Working Capital
(505.19) (87.23) (462.22) (462.16)
Capital Expenditures
(77.80) (103.37) (5.26) (1.95)
Net Current Asset Value
(821.95) (587.59) (963.97) (968.06)
EV/EBIT
40.15 98.35 2,353.18 2,353.18
Capex to Sales
0.75 1.18 0.06 0.02
Price to Operating Income
28.83 82.13 887.81 887.81
Other line items
Average Receivables
29.53 29.35 29.51 29.71
Average Payables
83.75 47.29 48.68 66.98
Average Assets
1,826.94 1,867.58 1,764.97 1,828.90
Average Common Equity
776.82 854.78 638.26 647.25

Fold the line items

Columns are period end dates · fundamentals updated Nov 18, 2026